<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28793919</article-id><article-id pub-id-type="pmc">5551009</article-id><article-id pub-id-type="publisher-id">2117</article-id><article-id pub-id-type="doi">10.1186/s13063-017-2117-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Arenaza</surname><given-names>Lide</given-names></name><address><email>laretxo@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Medrano</surname><given-names>Mar&#x000ed;a</given-names></name><address><email>mari_medra@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Amasene</surname><given-names>Mar&#x000ed;a</given-names></name><address><email>mamasene001@ikasle.ehu.eus</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez-Vigil</surname><given-names>Beatriz</given-names></name><address><email>brodriguezvigil@osatek.eus</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>D&#x000ed;ez</surname><given-names>Ignacio</given-names></name><address><email>Ignacio.diez.lopez@osakidetza.eus</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gra&#x000f1;a</surname><given-names>Manuel</given-names></name><address><email>ccpgrrom@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Tobalina</surname><given-names>Ignacio</given-names></name><address><email>Ignacio.tobalina.larrea@osakidetza.eus</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Maiz</surname><given-names>Edurne</given-names></name><address><email>edurne.maiz@ehu.eus</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Arteche</surname><given-names>Edurne</given-names></name><address><email>EDURNE.ARTECHEDAUBAGNA@osakidetza.eus</email></address><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Larrarte</surname><given-names>Eider</given-names></name><address><email>eider.larrarte@tecnalia.com</email></address><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Huybrechts</surname><given-names>Inge</given-names></name><address><email>inge.huybrechts@ugent.be</email></address><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Catherine L.</given-names></name><address><email>katie.davis@augusta.edu</email></address><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Ruiz</surname><given-names>Jonatan R.</given-names></name><address><email>ruizj@ugr.es</email></address><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Ortega</surname><given-names>Francisco B.</given-names></name><address><email>ortegaf@ugr.es</email></address><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Margareto</surname><given-names>Javier</given-names></name><address><email>javier.margareto@tecnalia.com</email></address><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4334-3287</contrib-id><name><surname>Labayen</surname><given-names>Idoia</given-names></name><address><email>idoia.labayen@unavarra.es</email></address><xref ref-type="aff" rid="Aff12">12</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121671098</institution-id><institution-id institution-id-type="GRID">grid.11480.3c</institution-id><institution>Nutrition, Exercise and Health Research group, Elikadura, Ariketa Fisikoa eta Osasuna, ELIKOS group, Department of Nutrition and Food Science, </institution><institution>University of the Basque Country, UPV/EHU, </institution></institution-wrap>Vitoria-Gasteiz, Spain </aff><aff id="Aff2"><label>2</label>Department of Magnetic Resonance Imaging, Osatek, University Hospital of Alava (HUA), Vitoria-Gasteiz, Spain </aff><aff id="Aff3"><label>3</label>Paediatric Endocrinology Unit, University Hospital of Araba (HUA), Vitoria-Gasteiz, Spain </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121671098</institution-id><institution-id institution-id-type="GRID">grid.11480.3c</institution-id><institution>Computational Intelligence Group, </institution><institution>University of the Basque Country, UPV/EHU, </institution></institution-wrap>Donostia, Spain </aff><aff id="Aff5"><label>5</label>Department of Nuclear Medicine, University Hospital of Araba (HUA), Vitoria-Gasteiz, Spain </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121671098</institution-id><institution-id institution-id-type="GRID">grid.11480.3c</institution-id><institution>Department of Personality, Assessment and Psychological Treatment, </institution><institution>University of the Basque Country, UPV/EHU, </institution></institution-wrap>San Sebasti&#x000e1;n-Donostia, Spain </aff><aff id="Aff7"><label>7</label>Department of Radiology, University Hospital of Araba (HUA), Vitoria-Gasteiz, Spain </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1764 7775</institution-id><institution-id institution-id-type="GRID">grid.13753.33</institution-id><institution/><institution>Technological Services Division, Health and quality of life, TECNALIA, </institution></institution-wrap>Mi&#x000f1;ano, Spain </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000000405980095</institution-id><institution-id institution-id-type="GRID">grid.17703.32</institution-id><institution/><institution>Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, </institution></institution-wrap>Lyon, France </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2284 9329</institution-id><institution-id institution-id-type="GRID">grid.410427.4</institution-id><institution>Georgia Prevention Institute, Medical College of Georgia, </institution><institution>Augusta University, </institution></institution-wrap>Augusta, GA USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121678994</institution-id><institution-id institution-id-type="GRID">grid.4489.1</institution-id><institution>PROmoting FITness and Health through physical activity research group (PROFITH), Department of Physical Education and Sports, Faculty of Sport Sciences, </institution><institution>University of Granada, </institution></institution-wrap>Grenada, Spain </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2174 6440</institution-id><institution-id institution-id-type="GRID">grid.410476.0</institution-id><institution>Department of Health Sciences, </institution><institution>Public University of Navarra, </institution></institution-wrap>Pamplona, Spain </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>18</volume><elocation-id>372</elocation-id><history><date date-type="received"><day>22</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The global pandemic of obesity has led to an increased risk for prediabetes and type-2 diabetes (T2D). The aims of the current project are: (1) to evaluate the effect of a 22-week family based intervention program, including supervised exercise, on insulin resistance syndrome (IRS) risk in children with a high risk of developing T2D and (2) to identify the profile of microRNA in circulating exosomes and in peripheral blood mononuclear cells in children with a high risk of developing T2D and its response to a multidisciplinary intervention program including exercise.</p></sec><sec><title>Methods</title><p id="Par2">A total of 84 children, aged 8&#x02013;12 years, with a high risk of T2D will be included and randomly assigned to control (<italic>N</italic>&#x02009;=&#x02009;42) or intervention (<italic>N</italic>&#x02009;=&#x02009;42) groups. The control group will receive a family based lifestyle education and psycho-educational program (2 days/month), while the intervention group will attend the same lifestyle education and psycho-educational program plus the exercise program (3 days/week, 90 min per session including warm-up, moderate to vigorous aerobic activities, and strength exercises). The following measurements will be evaluated at baseline prior to randomization and after the intervention: fasting insulin, glucose and hemoglobin A1c; body composition (dual-energy X-ray absorptiometry); ectopic fat (magnetic resonance imaging); microRNA expression in circulating exosomes and in peripheral blood mononuclear cells (MiSeq; Illumina); cardiorespiratory fitness (cardiopulmonary exercise testing); dietary habits and physical activity (accelerometry).</p></sec><sec><title>Discussion</title><p id="Par3">Prevention and identification of children with a high risk of developing T2D could help to improve their cardiovascular health and to reduce the comorbidities associated with obesity.</p></sec><sec><title>Trial registration</title><p id="Par4">ClinicalTrials.gov, ID: <ext-link ext-link-type="uri" xlink:href="https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0006UP9&#x00026;selectaction=Edit&#x00026;uid=U0002H58&#x00026;ts=2&#x00026;cx=-oi6ftp">NCT03027726</ext-link>. Registered on 16 January 2017.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s13063-017-2117-y) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Type-2 diabetes</kwd><kwd>Children</kwd><kwd>Exercise</kwd><kwd>Family based lifestyle intervention program</kwd><kwd>miRNA</kwd><kwd>Ectopic fat</kwd></kwd-group><funding-group><award-group><funding-source><institution>Spanish Ministry of Industry and Competitiveness</institution></funding-source><award-id>DEP2016-78377-R</award-id><principal-award-recipient><name><surname>Labayen</surname><given-names>Idoia</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par15">Type-2 diabetes (T2D) is an important cause of premature death and disability as well as a costly disease affecting more than 415 million people worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. This chronic disease is an important risk factor for developing accelerated cardiovascular disease and is the leading cause of microvascular complications such as end-stage renal disease, blindness and limb amputations. T2D was traditionally viewed as an adult-onset disease; however, over the last two decades scientific literature shows a global and dramatic increase in the incidence of T2D in youth [<xref ref-type="bibr" rid="CR2">2</xref>], secondary to the coincident pandemic of childhood obesity [<xref ref-type="bibr" rid="CR3">3</xref>]. The life-time risk of developing microvascular and macrovascular complications and mortality in early adulthood can be expected to be higher when the onset is already in children/adolescents rather than in adults with T2D or insulin resistance syndrome (IRS) due to the longer duration of the disease and greater duration of glycemic exposure [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par16">As a consequence of the high rates of obesity and diabetes risk, health and scientific organizations demand urgent early preventive actions for increasing life expectancy and quality of life of overweight/obese children at a high risk of T2D [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. T2D in youth is largely preventable through lifestyle intervention programs based on increasing physical activity levels, improving dietary habits and promoting a healthy body weight [<xref ref-type="bibr" rid="CR8">8</xref>]. Likewise, overweight and obesity are the strongest risk factors for insulin resistance and T2D [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. However, long-term success rates of lifestyle intervention programs focused on T2D prevention or treatment in children are usually less than 10% [<xref ref-type="bibr" rid="CR11">11</xref>]. The etiology of this apparent inefficiency of lifestyle intervention programs is multifactorial: lack of multidisciplinary approaches, high rates of depression or anxiety which affect the adherence to the program, insufficient involvement of the parents, etc. [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Therefore, there is a need for studies examining the effect of family based multidisciplinary intervention programs on metabolic abnormalities closely associated to T2D risk in order to give appropriate treatment/prevention options for prediabetes and T2D in overweight/obese children.</p><p id="Par17">In adults, lifestyle intervention programs based on diet and physical activity level modifications have proven to be effective in decreasing the rate of the progression from glucose intolerance or prediabetes to T2D [<xref ref-type="bibr" rid="CR6">6</xref>]. However, body mass loss achieved reducing energy intake is the cornerstone to the treatment in adults [<xref ref-type="bibr" rid="CR6">6</xref>]. In children, energy restriction programs may compromise healthy growth and development, and increase the risk of disordered eating behaviors.</p><p id="Par18">There is substantial evidence indicating that lifestyle behaviors associated to obesity and T2D are established in childhood and are difficult to modify into adulthood [<xref ref-type="bibr" rid="CR15">15</xref>]. The adoption of healthy dietary habits is essential in the prevention of the onset of T2D in children at high risk of T2D. Consumption of sugar-sweetened beverages [<xref ref-type="bibr" rid="CR16">16</xref>], energy-dense diets [<xref ref-type="bibr" rid="CR17">17</xref>], reduced consumption of fiber, fruits and vegetables [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], breakfast and meal skipping [<xref ref-type="bibr" rid="CR20">20</xref>] or eating frequency [<xref ref-type="bibr" rid="CR21">21</xref>] have been consistently associated with obesity and T2D risk. In addition, previous studies have shown the association of low physical activity levels and sedentary behaviors with insulin resistance in children [<xref ref-type="bibr" rid="CR22">22</xref>]. Moreover, short sleep duration and poor sleep quality have been proposed as predictors of obesity and T2D onset in children and adults [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par19">Family based lifestyle modification interventions (i.e., targeting both the child and parent) seem to be the most efficacious treatment format for childhood obesity [<xref ref-type="bibr" rid="CR25">25</xref>]. In addition, psychological and emotional factors are important determinants of lifestyle modifications [<xref ref-type="bibr" rid="CR26">26</xref>] and depressive symptoms and psychological stress have negative effects on dietary behaviors and physical activity levels [<xref ref-type="bibr" rid="CR27">27</xref>]. Moreover, overweight/obese children have an impaired psychological wellbeing compared to their non-overweight peers [<xref ref-type="bibr" rid="CR28">28</xref>]. In this context, multicomponent lifestyle management aiming to promote healthy dietary and sleep habits, increase physical activity levels and reduce sedentary behaviors may contribute to the prevention of T2D in the short and the long term [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par20">Exercise is a critical component for T2D prevention and management. Likewise, regular physical activity improves insulin sensitivity in diabetic or prediabetic children [<xref ref-type="bibr" rid="CR31">31</xref>]. Previous studies have shown that exercise training reduces insulin resistance in overweight/obese youth, even without body mass loss [<xref ref-type="bibr" rid="CR32">32</xref>]. Interestingly, Davis et al. reported that the benefit of aerobic training on insulin resistance was dose-dependent in overweight children regardless of sex and race [<xref ref-type="bibr" rid="CR33">33</xref>]. However, although exercise is recommended for overweight/obese children, optimal exercise prescription describing type (aerobic training, resistance training or combined training) and intensity (moderate or vigorous) of exercise needed to reduce T2D risk in children is unclear.</p><p id="Par21">Obesity, insulin resistance and T2D are caused by a combination of genetic, epigenetic and environmental factors such as diet and exercise. During the last few years, a growing number of studies demonstrate that small, non-coding, ribonucleic acid (RNA) molecules that function as regulators of gene expression, microRNAs (miRNAs), may be involved in the pathogenesis of obesity, diabetes and related metabolic disorders [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Several studies observed that miRNAs play a significant role in insulin production and secretion, pancreatic islet development and &#x003b2;-cell differentiation, and that they are implicated in several aspects of glucose homeostasis and lipid metabolism associated with the pathogenesis and progress of T2D and obesity [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR38">38</xref>]. The stability and presence of miRNAs in a variety of readily accessible cell types including body fluids, as well as their often tissue- and disease-specific expression, and the possibility to measure them with high sensitivity and specificity, render them a potential source of clinical biomarkers of T2D risk [<xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, miRNAs reflect individual biological adaptations to physiological changes or environmental exposures such as diet or exercise. Likewise, measurement of miRNAs presents an opportunity to evaluate biological changes associated with lifestyle interventions for the reduction of metabolic disorders associated with T2D risk such as insulin resistance, ectopic fat accumulation, inflammation, etc. The majority of the studies aiming to identify miRNAs as biomarkers of obesity and T2D have been conducted in small samples of adults. Previous reports observed changes in circulating miRNA profile after metformin therapy [<xref ref-type="bibr" rid="CR38">38</xref>] or exercise in prediabetic adults [<xref ref-type="bibr" rid="CR40">40</xref>]. In obese children, several miRNAs have been proposed as biomarkers of endothelial dysfunction and dyslipidemia [<xref ref-type="bibr" rid="CR41">41</xref>]. As far as we are aware, there are no previous studies identifying the profile of miRNAs in children at a high risk of T2D and its response to a family based multidisciplinary intervention program including exercise.</p><p id="Par22">Therefore, the primary aims of the PREDIKID (Prevention of Diabetes in Kids) study are: (1) to evaluate the effect of a 22-week, family based, multidisciplinary intervention program including exercise on IRS in children with a high risk of developing T2D and (2) to identify the profile of microRNA in circulating exosomes and in peripheral blood mononuclear cells in children with a high risk of developing T2D and its response to a family based multidisciplinary intervention program including exercise.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Design</title><p id="Par23">The PREvention of DIabetes in KIDs (PREDIKID) study is a randomized clinical trial (RCT) (ClinicalTrials.gov, ID: NCT03027726) (see Additional file <xref rid="MOESM1" ref-type="media">1</xref> and Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> for the associated Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Checklist and Figure, respectively). Children will be randomly allocated to the control group or the exercise group and will be followed for 22 weeks. All the families included in the study will participate in a lifestyle education and psycho-educational program conducted by a multidisciplinary team of health care professionals (physicians, nutritionists and dieticians, psychologists and exercise specialist) and scientists. As both groups will receive the same lifestyle education and psycho-education program, differences in changes in outcome variables will be due to the additional effect of the exercise intervention. This study was reviewed and approved by the Ethics Committee of Clinical Investigation of Euskadi. All parents or legal guardians will sign an informed written consent and all the children will give their assent before being enrolled in the study. The informed consent will be obtained by the pediatricians participating in the recruitment.<fig id="Fig1"><label>Fig. 1</label><caption><p>Standard Protocol Items: Recommendations for Interventional Trials SPIRIT Figure. <italic>cIMT</italic> carotid intima media thickness; <italic>CRF</italic> cardiorespiratory fitness; <italic>HDL</italic> high-density lipoprotein; <italic>SAAT</italic> subcutaneous abdominal fat; <italic>TG</italic> triglycerides; <italic>VAT</italic> visceral abdominal fat</p></caption><graphic xlink:href="13063_2017_2117_Fig1_HTML" id="MO1"/></fig>
</p><sec id="Sec4"><title>Participants and selection criteria</title><p id="Par24">Participants will be recruited by pediatricians from the Pediatric Endocrinology Unit of the University Hospital of Txagorritxu and from primary care clinics (Vitoria-Gasteiz, Spain). Children aged between 8 and 12 years, meeting the international criteria for classification of T2D risk [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR42">42</xref>], and having at least one parent or caregiver willing to participate in the program sessions, will be included (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Eligibility criteria for the PREvention of DIabetes in KIDs (PREDIKID) study</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Inclusion criteria</td></tr><tr><td>&#x02003;Aged 8&#x02013;12 years</td></tr><tr><td>&#x02003;Criteria for the classification of risk of T2D [<xref ref-type="bibr" rid="CR1">1</xref>]<sup>a</sup>
</td></tr><tr><td>1. Obesity status according to the World Obesity Federation [<xref ref-type="bibr" rid="CR24">24</xref>] 2. Overweight and the presence of at least one of the following metabolic abnormalities: 2.1. Family history of T2D in first- or second-degree relative; Signs of insulin resistance or conditions associated with insulin resistance (acanthosis nigricans, HOMA&#x02009;&#x0003e;&#x02009;2.5, glucose between 100 and 125 mg/dL; Hypertension (systolic blood pressure&#x02009;&#x02265;&#x02009;130 mmHg and/or diastolic blood pressure&#x02009;&#x02265;&#x02009;85 mmHg); Dyslipidemia (HDL&#x02009;&#x0003c;&#x02009;40 mg/dL, TG&#x02009;&#x0003e;&#x02009;150 mg/dL); 2.2. Ethnic minority with higher risk</td></tr><tr><td>&#x02003;To have at least one parent or caregiver willing to participate in the program sessions</td></tr><tr><td>Exclusion criteria</td></tr><tr><td>&#x02003;Not available for assessment and intervention sessions</td></tr><tr><td>&#x02003;Medical conditions or medications that would affect study results or limit physical exercise</td></tr></tbody></table><table-wrap-foot><p>
<italic>PREDIKID</italic> PREvention of DIabetes in Kids. <sup>a</sup>According to the International Diabetes Federation [<xref ref-type="bibr" rid="CR1">1</xref>]. <italic>T2D</italic> type-2 diabetes; <italic>TG</italic> triglycerides; <italic>HDL</italic> high-density lipoprotein; <italic>HOMA</italic> homeostatic model assessment</p></table-wrap-foot></table-wrap>
</p><p id="Par25">A pre-screening appointment will be scheduled with the investigation team to assess eligibility, family needs and commitment. Parents will provide the child&#x02019;s and family health history and detailed contact information. After completion of the informed consent process, children will undergo anthropometric screening (height, body mass and waist circumference), complete physical examination and blood sampling, and will be selected for inclusion in the study if they meet the inclusion criteria (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Every child meeting the inclusion criteria will go through maximal exercise testing guarantee. Children with any medical condition that could affect the results of the study or that limits physical activity will be excluded.</p></sec><sec id="Sec5"><title>Sample size calculation</title><p id="Par26">Insulin resistance is the primary outcome of this study. We expect that pre-post intervention differences in our design consisting in two experimental groups, control and exercise group, will have a size effect (Cohen&#x02019;s <italic>d</italic>) of 0.7 for insulin resistance (i.e., homeostatic model assessment, HOMA) (<italic>N</italic>&#x02009;=&#x02009;34 in each group, 80% power and <italic>&#x003b1;</italic> of 0.05). These effect size estimates are based on previous studies performed in overweight children with similar age range and a with intervention programs including supervised exercise [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. We observed in one previous study, in which the effect of the same intervention program was tested on hepatic fat in overweight/obese children, losses to follow-up of approximately 7% (data not shown). Previous studies have reported losses to follow-up of between 4 and 17%. Assuming a maximum loss of follow-up of 20%, we decided to recruit a total of 84 children (50% girls), 42 children for each group.</p></sec><sec id="Sec6"><title>Randomization</title><p id="Par27">Eligible participants will be randomly assigned after completing the baseline measurements to either the control group or the or exercise group (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Randomization of the participants into the control or exercise group will be done using Statistical Package for Social Sciences (IBM SPSS Statistics for Windows, version 21, Armonk, NY, USA) by an independent researcher. Assessment staff will be blinded to participant randomization assignment. Participants and their parents or guardians will be explicitly informed of the group to which they will be assigned, as well as of the study hypotheses. As exercise is potentially beneficial for the health of the children recruited in this trial, the waiting list control group strategy will be used, which means that the control group will receive the same exercise program when the post-intervention evaluations are finished.<fig id="Fig2"><label>Fig. 2</label><caption><p>Planned study design</p></caption><graphic xlink:href="13063_2017_2117_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec7"><title>Family based healthy lifestyle education and psycho-educational intervention</title><p id="Par28">Families in the control and the exercise groups will attend both the healthy lifestyle education and psycho-education program once every 2 weeks (11 sessions over 22 weeks) for 90 min (45 min in the healthy lifestyle education program and 45 min in the psycho-educational intervention). The design of the programs has been published elsewhere [<xref ref-type="bibr" rid="CR45">45</xref>]. Briefly, the sessions of the healthy lifestyle education and psycho-educational interventions will be developed simultaneously and delivered to both parents (or caregivers) and children, separately.</p><p id="Par29">The family based healthy lifestyle education program will be conducted by experienced nutritionists. The aim of the program will be in promoting changes in lifestyle behaviors strongly associated to obesity and T2D risk: promoting healthy dietary habits (reducing the intake of sugar, sugar-sweetened beverages and energy-dense foods, enhancing the daily consumption of fruits and vegetables, promoting breakfast and eating five meals/day), increasing regular physical activity levels, reducing time spent in sedentary behaviors and promoting sleep hygiene and adequate sleep duration.</p><p id="Par30">The aims of the psycho-educational program will be to provide parental skills to optimize the family environment in order to make positive changes in their lifestyles and to learn assertive communication skills. The program will also provide skills to children for managing the emotions and feelings that they are experiencing and to improve their self-esteem and psychological wellbeing.</p></sec><sec id="Sec8"><title>Exercise training intervention</title><p id="Par31">The exercise group will do exercise 3 days/week, 90 min per session, over a 22-week period. The program will be open to the families 5 days per week to choose a total of 3 days/week. Sessions will be designed and supervised by exercise specialists. The design of the exercise program has been published elsewhere [<xref ref-type="bibr" rid="CR45">45</xref>]. Briefly, the program consists of cardiovascular endurance (60 min) and muscle strength exercises (10 min). The sessions also include 10 min of warm-up period, 5 min for giving instructions and 5 min of cool-down period at the end, consisting mainly of stretching exercises. Moderate to vigorous intensity aerobic workout is the main part of the exercise session (60 min) and consists of games, circuits and start-and-stop activities. The emphasis of the program is on intensity doing special emphasis on high intensity activities (above 75% of maximal heart rate (HRmax) obtained from either the cardiopulmonary exercise test in the laboratory or the 20-m shuttle run test) and enjoyment. Participants will wear a heart rate monitor (Polar RS300X) during the exercise sessions to ensure achievement of the target heart rate zone. Heart rate monitors will be programmed according to individual percentage of HRmax as follows: (1) very light intensity: from 50 to 57% of HRmax, (2) light intensity: from&#x02009;&#x0003e;57 to 64% of HRmax, (3) moderate intensity, from&#x02009;&#x0003e;64 to 76% HRmax, (4) high intensity or vigorous: from&#x02009;&#x0003e;76 to 96% HRmax and (5) maximal intensity: &#x0003e;&#x02009;96% of HRmax.</p></sec></sec><sec id="Sec9"><title>Participant retention and adherence</title><p id="Par32">The success of the intervention is strongly dependent on enjoyment and active participation. In order to motivate children&#x02019;s active participation, the staff will use several strategies to celebrate success achieving the proposed objectives in both the healthy lifestyle education and the exercise programs: celebrate and recognize their efforts, reward with smiley emoticons, etc. Children who complete the program successfully will be rewarded with a certificate of completion. The attendance to the lifestyle education and psycho-education programs and of the exercise program will be recorded. Children will be marked as absent when: (1) the child does not attend the exercise session or does not participate in the proposed activities and (2) the child and at least one parent/caregiver do not attend one session of the healthy lifestyle education and psycho-educational programs.</p></sec><sec id="Sec10"><title>Outcome measures for the first objective</title><p id="Par33">IRS and the risk of T2D is characterized by excess adiposity, low levels of insulin sensitivity, dyslipidemia and hypertension. In the current project, the primary outcome is insulin resistance. Secondary outcome variables include total, abdominal and visceral adiposity, ectopic fat (hepatic and pancreatic fat), cardiorespiratory fitness, cardiovascular disease risk factors and inflammation markers, hepatokines and adipokines (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Primary and secondary outcomes will be evaluated at baseline and repeated after 22 weeks of intervention (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Post-intervention measurements will be scheduled within 3 days following the last healthy lifestyle program session or exercise session in the control or in the exercise group, respectively.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of the methodology of primary and secondary outcome measurements and potential confounders in the PREvention of DIabetes in KIDs (PREDIKID) study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Measure</th><th>Methodology</th></tr></thead><tbody><tr><td colspan="2">Primary outcomes</td></tr><tr><td>&#x02003;Insulin resistance</td><td>Homeostatic model assessment (HOMA), biochemical analyses</td></tr><tr><td>&#x02003;Expression of miRNA in circulating exosomes and white blood cells</td><td>RNA-seq methodology</td></tr><tr><td colspan="2">Secondary outcomes</td></tr><tr><td colspan="2">&#x02003;Physical measures</td></tr><tr><td>&#x02003;&#x02003;Body mass (kg)</td><td>Scale</td></tr><tr><td>&#x02003;&#x02003;Height (cm)</td><td>Stadiometer</td></tr><tr><td>&#x02003;&#x02003;Waist circumference (cm)</td><td>Non-elastic tape</td></tr><tr><td>&#x02003;&#x02003;Blood pressure (mmHg)</td><td>Oscillometric monitor device</td></tr><tr><td>&#x02003;&#x02003;Body fat (%)</td><td>Dual X-ray absorptiometry</td></tr><tr><td>&#x02003;&#x02003;Abdominal adiposity (g)</td><td>Dual X-ray absorptiometry</td></tr><tr><td>&#x02003;&#x02003;Visceral abdominal adiposity (cm<sup>2</sup>)</td><td>Magnetic resonance imaging</td></tr><tr><td>&#x02003;&#x02003;Hepatic fat (%)</td><td>Magnetic resonance imaging</td></tr><tr><td>&#x02003;&#x02003;Pancreatic fat (%)</td><td>Magnetic resonance imaging</td></tr><tr><td>&#x02003;&#x02003;Carotid intima medial thickness (mm)</td><td>Doppler ultrasonography</td></tr><tr><td colspan="2">&#x02003;Biochemical measures</td></tr><tr><td>&#x02003;&#x02003;Glucose (mg/dL)</td><td>Enzymatic spectrophotometry</td></tr><tr><td>&#x02003;&#x02003;Insulin, leptin, adiponectine, fetuin-A, FGF21</td><td>Enzyme-Linked Immunosorbent Assay</td></tr><tr><td>&#x02003;&#x02003;Hemoglobin A1c</td><td>Enzymatic tests</td></tr><tr><td>&#x02003;&#x02003;Total cholesterol, HDL- and LDL-cholesterol (mg/dL)</td><td>Enzymatic spectrophotometry</td></tr><tr><td>&#x02003;&#x02003;Triglycerides (mg/dL)</td><td>Enzymatic spectrophotometry</td></tr><tr><td>&#x02003;&#x02003;Alanine aminotransferase (U/L)</td><td>Enzymatic tests</td></tr><tr><td>&#x02003;&#x02003;Aspartate aminotransferase (U/L)</td><td>Enzymatic tests</td></tr><tr><td>&#x02003;&#x02003;Gamma glutamyl transferase (U/L)</td><td>Enzymatic tests</td></tr><tr><td>&#x02003;&#x02003;C-reactive protein (g/dL)</td><td>Enzyme immunoassay</td></tr><tr><td>&#x02003;&#x02003;TSH, T3, T4</td><td>Radioimmunoassay</td></tr><tr><td>&#x02003;&#x02003;Uric acid (mg/dL)</td><td>Enzymatic spectrophotometry</td></tr><tr><td>&#x02003;&#x02003;Urea, bilirubin</td><td>Enzymatic spectrophotometry</td></tr><tr><td>&#x02003;Cardiorespiratory fitness</td><td>20-m shuttle run test<break/>Cardiopulmonary exercise test</td></tr><tr><td>&#x02003;Dietary assessment</td><td>24-h recalls and food frequency questionnaires</td></tr><tr><td>&#x02003;Physical activity assessment</td><td>Accelerometry and questionnaires</td></tr><tr><td>&#x02003;Sleeping habits</td><td>Accelerometry and questionnaires</td></tr><tr><td>&#x02003;Sedentary behaviors</td><td>Questionnaires</td></tr><tr><td colspan="2">Potential confounders</td></tr><tr><td>&#x02003;Pubertal development (Tanner stage)</td><td>Physical examination</td></tr><tr><td colspan="2">&#x02003;Sociodemographic variables</td></tr><tr><td>&#x02003;Socioeconomic status</td><td>Questionnaires</td></tr><tr><td>&#x02003;Neonatal variables</td><td>Health booklets and questionnaires</td></tr><tr><td>&#x02003;Family medical history</td><td>Questionnaires</td></tr><tr><td>&#x02003;Demographic characteristics</td><td>Questionnaires</td></tr></tbody></table><table-wrap-foot><p>
<italic>PREDIKID</italic> Prevention of Diabetes in Kids; <italic>FGF21</italic> fibroblast growth factor 21; <italic>HDL</italic> high-density lipoprotein; <italic>LDL</italic> low-density lipoprotein; <italic>miRNA</italic> micro RNA; <italic>TSH</italic> thyroid stimulating hormone; <italic>T3</italic> triiodothyronine; <italic>T4</italic> free thyroxine</p></table-wrap-foot></table-wrap>
</p><sec id="Sec11"><title>Primary outcome measure: insulin resistance</title><p id="Par34">HOMA has been shown to be the more reliable method to assess insulin resistance in children [<xref ref-type="bibr" rid="CR46">46</xref>]. The computer-generated HOMA will be used [<xref ref-type="bibr" rid="CR47">47</xref>].</p></sec><sec id="Sec12"><title>Secondary outcomes</title><sec id="FPar1"><title>Anthropometry and blood pressure</title><p id="Par35">Body mass (SECA 760), height (SECA 220) and waist circumference (SECA 200) will be measured following standard protocols at least twice until consistent measures are obtained and, thereafter, Body Mass Index (BMI) and waist to height ratio will be calculated. Systolic and diastolic blood pressure measurements will be performed following the recommendations for children [<xref ref-type="bibr" rid="CR48">48</xref>] using an arm blood pressure oscillometric monitor device (OMRON&#x000ae; M6).</p></sec><sec id="FPar2"><title>Total, abdominal and visceral adiposity</title><p id="Par36">In children, the role of total, abdominal and visceral fat accumulation in the development of IRS, and ultimately T2D, is well established. One recent report observed that every additional 1% of adiposity at 8&#x02013;10 years decreased insulin sensitivity by 2.9% 2 years later [<xref ref-type="bibr" rid="CR22">22</xref>]. Total and abdominal adiposity will be measured by dual energy X-ray absorptiometry (HOLOGIC, QDR 4500 W). Visceral adiposity will be measured by magnetic resonance imaging using a 1.5-T system (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany) equipped with a phased-array surface coil and a spine array coil. Automated visceral fat measurement will be achieved by image processing (Matlab, Matworks Inc., Natick, MA, USA).</p></sec><sec id="FPar3"><title>Ectopic fat</title><p id="Par37">Excess adiposity is associated with an accumulation of fat in multiple organs and tissues. Fat accumulation in the liver and pancreas promotes a pro-inflammatory state that may increase the risk of insulin resistance and T2D. Likewise, ectopic fat accumulation seems to be an important predictor of the onset of T2D in adolescents [<xref ref-type="bibr" rid="CR49">49</xref>]. Insulin sensitivity was 55% lower in adolescents with hepatic steatosis compared to those without fatty liver disease. Few studies have examined fat accumulation in the pancreas and its relationship with insulin resistance and T2D. Pancreatic steatosis seems to be associated with prediabetes in children increasing the risk of T2D and cardiovascular disease [<xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref>]. Nevertheless, other studies reported no significant associations of pancreatic fat and &#x003b2;-cell dysfunction [<xref ref-type="bibr" rid="CR53">53</xref>]. There are no previous studies examining the effect of either a lifestyle modification program or an exercise program on pancreatic fat. Hepatic and pancreatic fat will be measured by magnetic resonance imaging using a 1.5-T system (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany) equipped with a phased-array surface coil and a spine array coil.</p></sec><sec id="FPar4"><title>Cardiorespiratory fitness</title><p id="Par38">Cardiorespiratory fitness is an independent predictor of T2D in adults [<xref ref-type="bibr" rid="CR54">54</xref>]. In youths, there is evidence indicating a negative association between cardiorespiratory fitness and insulin resistance [<xref ref-type="bibr" rid="CR55">55</xref>]. Moreover, previous reports suggested that that the relationship between cardiorespiratory fitness and T2D may be mediated by an increased susceptibility to fat deposition in liver and pancreas, increasing thereby insulin resistance [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Cardiorespiratory fitness will be assessed by two different tests as published elsewhere [<xref ref-type="bibr" rid="CR45">45</xref>]: (1) the 20-m shuttle run test [<xref ref-type="bibr" rid="CR57">57</xref>]. We will use the equation reported by L&#x000e9;ger et al. [<xref ref-type="bibr" rid="CR57">57</xref>] to estimate the maximum oxygen consumption (VO<sub>2max</sub>, ml/kg/min) from the 20-m shuttle run test scores and (2) direct cardiopulmonary exercise progressive incremental treadmill test using the modified American College of Sports Medicine protocol with respiratory gas analysis to exhaustion [<xref ref-type="bibr" rid="CR58">58</xref>].</p></sec><sec id="FPar5"><title>Carotid intima-media thickness</title><p id="Par39">Early changes of atherosclerosis can be detected assessing carotid intima-media thickness (cIMT). In adolescents with T2D, Shah et al. reported that every 1% increase in hemoglobin A1c (HbA1c) or each year increase of the duration of the disease was associated with 30% higher cIMT [<xref ref-type="bibr" rid="CR59">59</xref>]. In children with obesity, cIMT was higher in those with prediabetes than in their counterparts with normal glucose tolerance [<xref ref-type="bibr" rid="CR60">60</xref>]. cIMT will be measured by ultrasound (General Electric, Logic S8 model) according to international recommendations. All studies will be done following a standardized scanning protocol for the right and left common carotid arteries. The common carotid artery bulb will be identified and the segments of common carotid arteries 1&#x02013;2 cm proximal to the bulb region will be scanned. During the end of the diastole cIMT will be measured in both carotids four times and mean cIMT and maximal cIMT will be calculated. Also in telediastole, two sides of maximal diameter of the common carotid, bulb and internal carotid will be measured.</p></sec><sec id="FPar6"><title>Inflammation and biochemical cardiovascular disease risk factors</title><p id="Par40">The obesity-associated chronic inflammatory process participates in the onset of T2D, although the underlying mechanisms are not well understood [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Several studies have suggested that inflammatory cytokines may influence insulin sensitivity, both directly and also indirectly mediated, by adipokines, such as leptin and adiponectin, and hepatokines such as fetuin-A and fibroblast-21 growth factor (FGF-21) [<xref ref-type="bibr" rid="CR62">62</xref>&#x02013;<xref ref-type="bibr" rid="CR65">65</xref>]. Biochemical variables will be measured from venous fasting blood samples obtained from each child by experienced nurses. Blood samples will be immediately centrifuged, aliquoted and stored at &#x02212;80 &#x000b0;C or below. This permits the measurement of a full set of cardiovascular markers including lipid profile (total cholesterol, HDL- and LDL-cholesterol and triglycerides), glucose, insulin, HbA1c, cytokines (e.g., tumor necrosis factor alpha and interleukin (IL)-6) adipokines (e.g., leptin and adiponectin), hepatokines (fetuin-A and FGF-21), liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase), C-reactive protein and uric acid. ELISA kits, Western blots and High Performance Liquid Chromatography-Mass Spectroscopy will be used to perform these analyses.</p></sec><sec id="FPar7"><title>Physical activity, sedentary behavior, dietary assessment and sleep</title><p id="Par41">We will assess all these lifestyle behaviors both at the beginning and the end of the intervention. Children will wear an accelerometer on the non-dominant wrist (ActiSleep, Actigraph, Pensacola, FL, USA) for seven consecutive days for 24 h to record physical activity intensity levels and patterns, as well as sleeping habits and participants will also complete a diary log. Sedentary behaviors, such as watching TV, playing computer games, playing video games or phone games and surfing the Internet, will be self-reported by the children using validated questionnaires [<xref ref-type="bibr" rid="CR66">66</xref>]. Dietary intake will be evaluated by two non-consecutive 24-h recalls within a period of 7 days by nutritionists and a self-reported semi-quantitative food frequency questionnaire.</p></sec></sec></sec><sec id="Sec13"><title>Outcome measures for the second objective</title><p id="Par42">Recently, miRNAs have emerged as key regulators of gene expression. T2D is associated with changes in the level of several miRNAs in pancreatic &#x003b2;-cells as well as in tissues such as liver, skeletal muscle or adipose tissue [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. Moreover, miRNA expression seems to participate in the regulation of the IRS mediated by the regulation of inflammatory processes [<xref ref-type="bibr" rid="CR39">39</xref>]. As has been mentioned in previous sections, the second primary aim of the present work is to characterize the miRNA species present in circulating white blood cells and exosomes, before and after the intervention program is applied. Our initial hypothesis is that the application of this program will have a direct impact on the miRNA species present in blood cells and exosomes, and that these changes will influence the physiological effects elicited by the exercise program.</p><sec id="Sec14"><title>Extraction and isolation of miRNAs from white blood cells and plasma</title><p id="Par43">Exosomes will be obtained from 1 ml of plasma using the Total Exosome Isolation Kit (Thermo Fisher Scientific) following manufacturer&#x02019;s protocols. RNA molecules will be isolated from white blood cells (buffy coat) and exosomal fractions using Qiagen miRNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer&#x02019;s instructions. Once isolated, RNA will be quantified using a fluorimetric method.</p></sec><sec id="Sec15"><title>Analysis and validation of miRNAs</title><p id="Par44">Species of miRNA present on samples of individual subjects, before and after the intervention program, will be analyzed using RNA-seq methodology on Illumina&#x02019;s MiSeq Next Generation Sequencing system. This workflow allows one to fully characterize the miRNA profile present in the samples analyzed (exosomes and white blood cells) and to quantify the expression levels of different miRNA species. In this sense, effects of the intervention program on the miRNA profile and on expression level of specific species can be inferred. Briefly, Illumina&#x02019;s TruSeq Small RNA Sample preparation kit will be used to generate sequencing libraries, from 1 &#x003bc;g of total RNA isolated from previous samples (either exosomes or white blood cells). Only 145 to 160 bp libraries will be selected for sequencing, as they include miRNA species (22&#x02013;30 bp plus adapters). Sequencing reactions will be performed on Illumina&#x02019;s MiSeq Reagent Kit V3, which supports to multiplex up to 10 samples on a single run, and single reads of 50 nt in length. Analysis of results, FASTQ files generation and sequence alignment will be performed using specific software packages (MiSeq Reporter, Bowtie, SAMtools, DESeq2 and miRDeep).</p></sec></sec><sec id="Sec16"><title>Confounding variables</title><sec id="Sec17"><title>Puberty stage</title><p id="Par45">At baseline, the pediatrician will evaluate Tanner staging by direct-examination breast palpation in girls and testicular measurement by orchidometer in boys.</p></sec><sec id="Sec18"><title>Sociodemographic variables</title><p id="Par46">Information about socioeconomic status, demographic characteristics and family medical history of obesity, diabetes, dyslipidemia and hypertension will be collected. Socioeconomic status will be evaluated using The Family Affluence Scale [<xref ref-type="bibr" rid="CR69">69</xref>] and parental education level and parental occupation. As demographic characteristics, date of birth, sex, ethnicity and family structure will be recorded.</p></sec></sec><sec id="Sec19"><title>Assessment of side effects</title><p id="Par47">All adverse effects or health problems attributable to the testing or exercise sessions will be recorded.</p></sec><sec id="Sec20"><title>Data management and monitoring</title><p id="Par48">Participants&#x02019; data will be identified only by a study number (starting with 001) and only the principal investigator and study coordinator will have access to identifiers that can link the data to the individual participant. Participants who drop out will be noted and their reasons documented. Data will be entered and stored on a standalone computer into excel and SPSS data files, and the information will be password protected. We will assure the quality of data entry by random checking of the data entered. Study data is only accessible by the researchers involved in the trial, and only the principal investigator and investigators in the project will have access to the data for analysis. The investigators will monitor that the informed consent process is conducted appropriately and that informed consent was obtained prior to proceeding with any study procedures. Only participants who meet study eligibility criteria will be enrolled. Data will be kept for 10 years after the research is completed and all data (electronic and hard copy) will be destroyed after the storage period. There is no data monitoring committee due to the characteristics of the current study.</p></sec><sec id="Sec21"><title>Data analyses plan</title><p id="Par49">All outcome variables will be checked for normality and results will be expressed as mean and standard deviation (SD) or median and ranges. Multiple regression analyses will be performed to examine the potential independent predictors of T2D risk. At baseline, differences in continuous variables between groups (control group vs. exercise group) will be analyzed by Student&#x02019;s <italic>t</italic> test or the Mann-Whitney <italic>U</italic> test, as appropriate. Differences in categorical variables at baseline between the two groups will be explored by chi-squared tests. Repeated-measured analysis of variance will be used to assess the effect of exercise (time (pre-post 22-weeks&#x02019; intervention)&#x02009;&#x000d7;&#x02009;group interactions) on the primary (insulin resistance) and secondary study (adiposity, ectopic fat, cardiorespiratory fitness, cardiovascular disease risk factors, inflammation markers, etc.) outcomes and the intention-to-treat principle will be applied. For sensitivity analyses, we will analyze the effect of the adherence to the program on the results of the intervention.</p></sec><sec id="Sec22"><title>Data dissemination plan</title><p id="Par50">The principal investigator will inform the parents about their child&#x02019;s health before and after the intervention program. The main results of the trial will be communicated to the health care professionals (pediatricians) in Vitoria-Gasteiz and other relevant groups (e.g., university academics), as well as to the public. Scientific articles will be also written.</p></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par51">The worldwide obesity pandemic and the increasing prevalence of T2D at younger ages are important public health issues with both individual and social costs. Likewise, research focusing on the prevention of T2D in pre-adolescent children is a high priority for public health. Scientific associations emphasize the need for evidence-based adiposity and IRS control treatments that may reduce T2D risk in children at a high risk [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par52">The primary aim of the PREDIKID project is to test the effect of a multidisciplinary program including supervised exercise in the reduction of IRS in pre-adolescents at a high risk to develop T2D that could serve as preventive model of T2D in childhood. The families participating in the study will receive an educational program including lifestyle, psychological and emotional aspects that the scientific literature implicates in the development and progression of obesity and T2D risk in childhood. Moreover, the exercise intervention of the PREDIKID study will obtain objective data about the effect of high intensity exercise on metabolic variables closely associated to T2D risk in children, such as insulin resistance, HbA1c, ectopic fat, total, abdominal and visceral adiposity, cIMT, cardiorespiratory fitness, adipokines, hepatokines and cytokines, blood pressure or lipid profile. We will examine clinical outcomes intimately associated with T2D using innovative technology and reference methods. Likewise, the PREDIKID project will help to better understand the relationship between hepatic and pancreatic fat and IRS and risk of T2D in children. In addition, the current study may offer relevant clinical information about the efficacy of a family based multidisciplinary intervention program that includes exercise on reducing ectopic fat, IRS and cardiovascular disease risk factors in children at a high risk of T2D.</p><p id="Par53">The pathophysiology of childhood obesity and associated comorbidities, such as T2D, is not well established. To date it is not clear why some children develop IRS and T2D, while others show the metabolically healthy phenotype [<xref ref-type="bibr" rid="CR70">70</xref>]. Biomarkers for early detection of children at risk of T2D would greatly improve the care of children with overweight/obesity. Hence, there is a need to search for clinically relevant markers with prognostic value for intervention success. Recently, miRNAs have been proposed as promising biomarkers in terms of both diagnosis and prognosis of obesity-related comorbidities [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. The PREDIKID project will help to identify miRNAs potentially associated with early onset of IRS in children with overweight/obesity. Moreover, the differential expression and responses in circulating miRNAs between the control group and the exercise group may help to understand the underlying mechanisms of the effect of exercise on IRS, as well as to predict individual variability to the intervention in overweight/obese children.</p><sec id="Sec24"><title>Trial status</title><p id="Par54">The recruitment started on March 2017, and is expected to finish in September 2018.</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec25"><title>Additional file</title><p id="Par62">
<media position="anchor" xlink:href="13063_2017_2117_MOESM1_ESM.doc" id="MOESM1"><label>Additional file 1:</label><caption><p>Recommendations for Interventional Trials (SPIRIT) Checklist. (DOC 122 kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p id="Par5">Body Mass Index</p></def></def-item><def-item><term>cIMT</term><def><p id="Par6">Carotid intima-media thickness</p></def></def-item><def-item><term>HDL</term><def><p id="Par7">High-density lipoprotein</p></def></def-item><def-item><term>HOMA</term><def><p id="Par8">Homeostatic model assessment</p></def></def-item><def-item><term>HRmax</term><def><p id="Par9">Maximal heart rate</p></def></def-item><def-item><term>IRS</term><def><p id="Par10">Insulin resistance syndrome</p></def></def-item><def-item><term>LDL</term><def><p id="Par11">Low-density lipoprotein</p></def></def-item><def-item><term>miRNAs</term><def><p id="Par12">MicroRNAs</p></def></def-item><def-item><term>PREDIKID</term><def><p id="Par13">Prevention of Diabetes in Kids</p></def></def-item><def-item><term>T2D</term><def><p id="Par14">Type-2 diabetes</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1186/s13063-017-2117-y) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><p>We acknowledge the pediatricians for their participation in the recruitment, the members involved in the assessments for their efforts and to Siemens Medical Systems for supplying the software to quantify hepatic fat, and to the pre- and post-graduate students for their collaboration in the exercise training sessions.</p><sec id="FPar8"><title>Funding</title><p id="Par55">The current project was supported by the Spanish Ministry of Industry and Competitiveness (DEP2016-78377-R), by &#x0201c;Fondos Estructurales de la Uni&#x000f3;n Europea (FEDER), Una manera de hacer Europa.&#x0201d; and by the University of the Basque Country (GIU14/21). This work was also supported by grants from Spanish Ministry of Economy and Competitiveness (RYC-2010-05957; RYC-2011-09011), Spanish Ministry of Education, Culture and Sports (FPU14/03329) and by the Education, Linguistic Policy and Culture Department of the Government of the Basque Country (PRE_2016_1_0057).</p></sec><sec id="FPar9"><title>Availability of data and materials</title><p id="Par56">Not applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>IL conceived the study and drafted the manuscript; IL, FOB and JM participated in its design. LA, MM, MA, EM and IL designed the intervention programs; BRR, ID, IT, MG, EA and EL are members of the assessment staff. All the authors critically read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar10"><title>Authors&#x02019; information</title><p id="Par57">Not applicable.</p></sec><sec id="FPar11"><title>Ethics approval and consent to participate</title><p id="Par58">This study was reviewed and approved by the Ethic Committee of Clinical Investigation of Euskadi (PI2014045). All parents or legal guardians will sign an informed written consent and all the children will give their assent before being enrolled in the study.</p></sec><sec id="FPar12"><title>Consent for publication</title><p id="Par59">Not applicable.</p></sec><sec id="FPar13"><title>Competing interests</title><p id="Par60">The authors declare that they have no competing interests.</p></sec><sec id="FPar14"><title>Publisher&#x02019;s Note</title><p id="Par61">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><article-title>International Diabetes Federation: a consensus on Type 2 diabetes prevention</article-title><source>Diabet Med.</source><year>2007</year><volume>24</volume><fpage>451</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2007.02157.x</pub-id><pub-id pub-id-type="pmid">17470191</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulgaron</surname><given-names>ER</given-names></name><name><surname>Delamater</surname><given-names>AM</given-names></name></person-group><article-title>Obesity and type 2 diabetes in children: epidemiology and treatment</article-title><source>Curr Diab Rep.</source><year>2014</year><volume>14</volume><fpage>508</fpage><pub-id pub-id-type="doi">10.1007/s11892-014-0508-y</pub-id><pub-id pub-id-type="pmid">24919749</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skinner</surname><given-names>AC</given-names></name><name><surname>Perrin</surname><given-names>EM</given-names></name><name><surname>Moss</surname><given-names>LA</given-names></name><name><surname>Skelton</surname><given-names>JA</given-names></name></person-group><article-title>Cardiometabolic risks and severity of obesity in children and young adults</article-title><source>N Engl J Med.</source><year>2015</year><volume>373</volume><fpage>1307</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1502821</pub-id><pub-id pub-id-type="pmid">26422721</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>ET</given-names></name><name><surname>Prosser</surname><given-names>LA</given-names></name><name><surname>Hoerger</surname><given-names>TJ</given-names></name><name><surname>Lieu</surname><given-names>T</given-names></name><name><surname>Ludwig</surname><given-names>DS</given-names></name><name><surname>Laffel</surname><given-names>LM</given-names></name></person-group><article-title>Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus</article-title><source>Diabet Med.</source><year>2012</year><volume>29</volume><fpage>453</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2011.03542.x</pub-id><pub-id pub-id-type="pmid">22150528</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amutha</surname><given-names>A</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name></person-group><article-title>Diabetes complications in childhood and adolescent onset type 2 diabetes&#x02014;a review</article-title><source>J Diabetes Complicat.</source><year>2016</year><volume>30</volume><fpage>951</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2016.02.009</pub-id><pub-id pub-id-type="pmid">26970673</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2016;39(Suppl):S36&#x02013;8.</mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mechanick</surname><given-names>JI</given-names></name><name><surname>Hurley</surname><given-names>DL</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name></person-group><article-title>Adiposity based chronic disease as a new diagnostic term: American Association of Clinical Endocrinologists and the American College of Endocrinology Position Statement</article-title><source>Endocr Pract.</source><year>2017</year><volume>23</volume><fpage>327</fpage><lpage>8</lpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberger</surname><given-names>J</given-names></name><name><surname>Daniels</surname><given-names>SR</given-names></name></person-group><article-title>Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism)</article-title><source>Circulation.</source><year>2003</year><volume>107</volume><fpage>1448</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000060923.07573.F2</pub-id><pub-id pub-id-type="pmid">12642369</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Bonito</surname><given-names>P</given-names></name><name><surname>Pacifico</surname><given-names>L</given-names></name><name><surname>Chiesa</surname><given-names>C</given-names></name><name><surname>Valerio</surname><given-names>G</given-names></name><name><surname>Miraglia Del Giudice</surname><given-names>E</given-names></name><name><surname>Maffeis</surname><given-names>C</given-names></name><name><surname>Morandi</surname><given-names>A</given-names></name><name><surname>Invitti</surname><given-names>C</given-names></name><name><surname>Licenziati</surname><given-names>MR</given-names></name><name><surname>Loche</surname><given-names>S</given-names></name><etal/></person-group><article-title>Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity</article-title><source>J Endocrinol Invest.</source><year>2017</year><volume>40</volume><fpage>409</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s40618-016-0576-8</pub-id><pub-id pub-id-type="pmid">27854028</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molnar</surname><given-names>D</given-names></name></person-group><article-title>The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents</article-title><source>Int J Obes Relat Metab Disord.</source><year>2004</year><volume>28</volume><issue>Suppl 3</issue><fpage>S70</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0802811</pub-id><pub-id pub-id-type="pmid">15543223</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onge</surname><given-names>ES</given-names></name><name><surname>Miller</surname><given-names>SA</given-names></name><name><surname>Motycka</surname><given-names>C</given-names></name><name><surname>DeBerry</surname><given-names>A</given-names></name></person-group><article-title>A review of the treatment of type 2 diabetes in children</article-title><source>J Pediatr Pharmacol Ther.</source><year>2015</year><volume>20</volume><fpage>4</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">25859165</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbestel</surname><given-names>V</given-names></name><name><surname>De Henauw</surname><given-names>S</given-names></name><name><surname>Barba</surname><given-names>G</given-names></name><name><surname>Eiben</surname><given-names>G</given-names></name><name><surname>Gallois</surname><given-names>K</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>C</given-names></name><name><surname>Konstabel</surname><given-names>K</given-names></name><name><surname>Maes</surname><given-names>L</given-names></name><name><surname>Marild</surname><given-names>S</given-names></name><name><surname>Molnar</surname><given-names>D</given-names></name><etal/></person-group><article-title>Effectiveness of the IDEFICS intervention on objectively measured physical activity and sedentary time in European children</article-title><source>Obes Rev.</source><year>2015</year><volume>16</volume><issue>Suppl 2</issue><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1111/obr.12348</pub-id><pub-id pub-id-type="pmid">26707016</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>RF</given-names></name><name><surname>Weston</surname><given-names>C</given-names></name><name><surname>Fawole</surname><given-names>O</given-names></name><name><surname>Bleich</surname><given-names>SN</given-names></name><name><surname>Cheskin</surname><given-names>LJ</given-names></name><name><surname>Showell</surname><given-names>NN</given-names></name><name><surname>Lau</surname><given-names>BD</given-names></name><etal/></person-group><article-title>What childhood obesity prevention programmes work? A systematic review and meta-analysis</article-title><source>Obes Rev.</source><year>2015</year><volume>16</volume><fpage>547</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/obr.12277</pub-id><pub-id pub-id-type="pmid">25893796</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinehr</surname><given-names>T</given-names></name></person-group><article-title>Type 2 diabetes mellitus in children and adolescents</article-title><source>World J Diabetes.</source><year>2013</year><volume>4</volume><fpage>270</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.4239/wjd.v4.i6.270</pub-id><pub-id pub-id-type="pmid">24379917</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobstein</surname><given-names>T</given-names></name><name><surname>Baur</surname><given-names>L</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name></person-group><article-title>Obesity in children and young people: a crisis in public health</article-title><source>Obes Rev.</source><year>2004</year><volume>5</volume><issue>Suppl 1</issue><fpage>4</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1111/j.1467-789X.2004.00133.x</pub-id><pub-id pub-id-type="pmid">15096099</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>VS</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us</article-title><source>J Am Coll Cardiol.</source><year>2015</year><volume>66</volume><fpage>1615</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2015.08.025</pub-id><pub-id pub-id-type="pmid">26429086</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouhani</surname><given-names>MH</given-names></name><name><surname>Haghighatdoost</surname><given-names>F</given-names></name><name><surname>Surkan</surname><given-names>PJ</given-names></name><name><surname>Azadbakht</surname><given-names>L</given-names></name></person-group><article-title>Associations between dietary energy density and obesity: a systematic review and meta-analysis of observational studies</article-title><source>Nutrition.</source><year>2016</year><volume>32</volume><fpage>1037</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2016.03.017</pub-id><pub-id pub-id-type="pmid">27238958</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollard</surname><given-names>RC</given-names></name><name><surname>Senechal</surname><given-names>M</given-names></name><name><surname>MacIntosh</surname><given-names>AC</given-names></name><name><surname>Hay</surname><given-names>J</given-names></name><name><surname>Wicklow</surname><given-names>BA</given-names></name><name><surname>Wittmeier</surname><given-names>KD</given-names></name><name><surname>Sellers</surname><given-names>EA</given-names></name><name><surname>Dean</surname><given-names>HJ</given-names></name><name><surname>Ryner</surname><given-names>L</given-names></name><name><surname>Berard</surname><given-names>L</given-names></name><name><surname>McGavock</surname><given-names>JM</given-names></name></person-group><article-title>Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes</article-title><source>Am J Clin Nutr.</source><year>2014</year><volume>99</volume><fpage>804</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3945/ajcn.113.079277</pub-id><pub-id pub-id-type="pmid">24522441</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>LT</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>GA</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name><name><surname>Spruijt-Metz</surname><given-names>D</given-names></name><name><surname>Davis</surname><given-names>JN</given-names></name></person-group><article-title>Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth</article-title><source>J Acad Nutr Diet.</source><year>2014</year><volume>114</volume><fpage>1776</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jand.2014.01.017</pub-id><pub-id pub-id-type="pmid">24685236</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>BT</given-names></name><name><surname>Cook</surname><given-names>LT</given-names></name><name><surname>Gyllenhammer</surname><given-names>LE</given-names></name><name><surname>Schraw</surname><given-names>JM</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>Spruijt-Metz</surname><given-names>D</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name><name><surname>Davis</surname><given-names>JN</given-names></name></person-group><article-title>Meal skipping linked to increased visceral adipose tissue and triglycerides in overweight minority youth</article-title><source>Obesity (Silver Spring).</source><year>2014</year><volume>22</volume><fpage>E77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/oby.20487</pub-id><pub-id pub-id-type="pmid">23613461</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>BT</given-names></name><name><surname>Shearrer</surname><given-names>GE</given-names></name><name><surname>Miller</surname><given-names>SJ</given-names></name><name><surname>Pasch</surname><given-names>KE</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>Davis</surname><given-names>JN</given-names></name></person-group><article-title>Increased eating frequency linked to decreased obesity and improved metabolic outcomes</article-title><source>Int J Obes (Lond)</source><year>2015</year><volume>39</volume><fpage>136</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/ijo.2014.81</pub-id><pub-id pub-id-type="pmid">24840081</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>M</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Barnett</surname><given-names>TA</given-names></name><name><surname>Mathieu</surname><given-names>ME</given-names></name><name><surname>Deladoey</surname><given-names>J</given-names></name><name><surname>Gray-Donald</surname><given-names>K</given-names></name></person-group><article-title>Influence of adiposity, physical activity, fitness, and screen time on insulin dynamics over 2 years in children</article-title><source>JAMA Pediatr.</source><year>2016</year><volume>170</volume><fpage>227</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.3909</pub-id><pub-id pub-id-type="pmid">26857733</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayin</surname><given-names>FK</given-names></name><name><surname>Buyukinan</surname><given-names>M</given-names></name></person-group><article-title>Sleep duration and media time have a major impact on insulin resistance and metabolic risk factors in obese children and adolescents</article-title><source>Child Obes.</source><year>2016</year><volume>12</volume><fpage>272</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1089/chi.2015.0126</pub-id><pub-id pub-id-type="pmid">26978730</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bernardi Rodrigues</surname><given-names>AM</given-names></name><name><surname>da Silva</surname><given-names>CC</given-names></name><name><surname>Vasques</surname><given-names>AC</given-names></name><name><surname>Camilo</surname><given-names>DF</given-names></name><name><surname>Barreiro</surname><given-names>F</given-names></name><name><surname>Cassani</surname><given-names>RS</given-names></name><name><surname>Zambon</surname><given-names>MP</given-names></name><name><surname>Antonio</surname><given-names>MA</given-names></name><name><surname>Geloneze</surname><given-names>B</given-names></name></person-group><article-title>Association of sleep deprivation with reduction in insulin sensitivity as assessed by the hyperglycemic clamp technique in adolescents</article-title><source>JAMA Pediatr.</source><year>2016</year><volume>170</volume><fpage>487</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.4365</pub-id><pub-id pub-id-type="pmid">26999405</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilfley</surname><given-names>DE</given-names></name><name><surname>Staiano</surname><given-names>AE</given-names></name><name><surname>Altman</surname><given-names>M</given-names></name><name><surname>Lindros</surname><given-names>J</given-names></name><name><surname>Lima</surname><given-names>A</given-names></name><name><surname>Hassink</surname><given-names>SG</given-names></name><name><surname>Dietz</surname><given-names>WH</given-names></name><name><surname>Cook</surname><given-names>S</given-names></name></person-group><article-title>Improving access and systems of care for evidence-based childhood obesity treatment: conference key findings and next steps</article-title><source>Obesity (Silver Spring)</source><year>2017</year><volume>25</volume><fpage>16</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1002/oby.21712</pub-id><pub-id pub-id-type="pmid">27925451</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elovainio</surname><given-names>M</given-names></name><name><surname>Pulkki-Raback</surname><given-names>L</given-names></name><name><surname>Hakulinen</surname><given-names>C</given-names></name><name><surname>Lehtimaki</surname><given-names>T</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Ronnemaa</surname><given-names>T</given-names></name><name><surname>Mikkila</surname><given-names>V</given-names></name><name><surname>Tossavainen</surname><given-names>P</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Hutri-Kahonen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Psychosocial environment in childhood and body mass index growth over 32 years</article-title><source>Prev Med.</source><year>2017</year><volume>97</volume><fpage>50</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.ypmed.2016.12.023</pub-id><pub-id pub-id-type="pmid">28039070</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olive</surname><given-names>LS</given-names></name><name><surname>Telford</surname><given-names>RM</given-names></name><name><surname>Byrne</surname><given-names>DG</given-names></name><name><surname>Abhayaratna</surname><given-names>WP</given-names></name><name><surname>Telford</surname><given-names>RD</given-names></name></person-group><article-title>Psychological distress leads to reduced physical activity and fitness in children: the Australian longitudinal LOOK study</article-title><source>J Behav Med.</source><year>2016</year><volume>39</volume><fpage>587</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s10865-016-9723-0</pub-id><pub-id pub-id-type="pmid">26894482</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>J</given-names></name><name><surname>Matthews</surname><given-names>L</given-names></name><name><surname>Cobley</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Sanders</surname><given-names>R</given-names></name><name><surname>Wiltshire</surname><given-names>HD</given-names></name><name><surname>Baker</surname><given-names>JS</given-names></name></person-group><article-title>Psychological consequences of childhood obesity: psychiatric comorbidity and prevention</article-title><source>Adolesc Health Med Ther.</source><year>2016</year><volume>7</volume><fpage>125</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.2147/AHMT.S101631</pub-id><pub-id pub-id-type="pmid">27881930</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkie</surname><given-names>HJ</given-names></name><name><surname>Standage</surname><given-names>M</given-names></name><name><surname>Gillison</surname><given-names>FB</given-names></name><name><surname>Cumming</surname><given-names>SP</given-names></name><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name></person-group><article-title>Multiple lifestyle behaviours and overweight and obesity among children aged 9&#x02013;11 years: results from the UK site of the International Study of Childhood Obesity, Lifestyle and the Environment</article-title><source>BMJ Open.</source><year>2016</year><volume>6</volume><fpage>e010677</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-010677</pub-id><pub-id pub-id-type="pmid">26911589</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemet</surname><given-names>D</given-names></name><name><surname>Barkan</surname><given-names>S</given-names></name><name><surname>Epstein</surname><given-names>Y</given-names></name><name><surname>Friedland</surname><given-names>O</given-names></name><name><surname>Kowen</surname><given-names>G</given-names></name><name><surname>Eliakim</surname><given-names>A</given-names></name></person-group><article-title>Short- and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity</article-title><source>Pediatrics.</source><year>2005</year><volume>115</volume><fpage>e443</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1542/peds.2004-2172</pub-id><pub-id pub-id-type="pmid">15805347</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pivovarov</surname><given-names>JA</given-names></name><name><surname>Taplin</surname><given-names>CE</given-names></name><name><surname>Riddell</surname><given-names>MC</given-names></name></person-group><article-title>Current perspectives on physical activity and exercise for youth with diabetes</article-title><source>Pediatr Diabetes.</source><year>2015</year><volume>16</volume><fpage>242</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1111/pedi.12272</pub-id><pub-id pub-id-type="pmid">25754326</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marson</surname><given-names>EC</given-names></name><name><surname>Delevatti</surname><given-names>RS</given-names></name><name><surname>Prado</surname><given-names>AK</given-names></name><name><surname>Netto</surname><given-names>N</given-names></name><name><surname>Kruel</surname><given-names>LF</given-names></name></person-group><article-title>Effects of aerobic, resistance, and combined exercise training on insulin resistance markers in overweight or obese children and adolescents: a systematic review and meta-analysis</article-title><source>Prev Med.</source><year>2016</year><volume>93</volume><fpage>211</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ypmed.2016.10.020</pub-id><pub-id pub-id-type="pmid">27773709</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>CL</given-names></name><name><surname>Pollock</surname><given-names>NK</given-names></name><name><surname>Waller</surname><given-names>JL</given-names></name><name><surname>Allison</surname><given-names>JD</given-names></name><name><surname>Dennis</surname><given-names>BA</given-names></name><name><surname>Bassali</surname><given-names>R</given-names></name><name><surname>Melendez</surname><given-names>A</given-names></name><name><surname>Boyle</surname><given-names>CA</given-names></name><name><surname>Gower</surname><given-names>BA</given-names></name></person-group><article-title>Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial</article-title><source>JAMA.</source><year>2012</year><volume>308</volume><fpage>1103</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1001/2012.jama.10762</pub-id><pub-id pub-id-type="pmid">22990269</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panera</surname><given-names>N</given-names></name><name><surname>Gnani</surname><given-names>D</given-names></name><name><surname>Crudele</surname><given-names>A</given-names></name><name><surname>Ceccarelli</surname><given-names>S</given-names></name><name><surname>Nobili</surname><given-names>V</given-names></name><name><surname>Alisi</surname><given-names>A</given-names></name></person-group><article-title>MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease</article-title><source>World J Gastroenterol.</source><year>2014</year><volume>20</volume><fpage>15079</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i41.15079</pub-id><pub-id pub-id-type="pmid">25386056</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campion</surname><given-names>J</given-names></name><name><surname>Milagro</surname><given-names>FI</given-names></name><name><surname>Martinez</surname><given-names>JA</given-names></name></person-group><article-title>Individuality and epigenetics in obesity</article-title><source>Obes Rev.</source><year>2009</year><volume>10</volume><fpage>383</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1111/j.1467-789X.2009.00595.x</pub-id><pub-id pub-id-type="pmid">19413700</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>G</given-names></name><name><surname>Ozcan</surname><given-names>S</given-names></name></person-group><article-title>Role of microRNAs in diabetes</article-title><source>Biochim Biophys Acta.</source><year>2008</year><volume>1779</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2008.06.010</pub-id><pub-id pub-id-type="pmid">18655850</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehwah</surname><given-names>MA</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name></person-group><article-title>MicroRNAs and type 2 diabetes/obesity</article-title><source>J Genet Genomics.</source><year>2012</year><volume>39</volume><fpage>11</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2011.11.007</pub-id><pub-id pub-id-type="pmid">22293113</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>FJ</given-names></name><name><surname>Mercader</surname><given-names>JM</given-names></name><name><surname>Moreno-Navarrete</surname><given-names>JM</given-names></name><name><surname>Rovira</surname><given-names>O</given-names></name><name><surname>Guerra</surname><given-names>E</given-names></name><name><surname>Esteve</surname><given-names>E</given-names></name><name><surname>Xifra</surname><given-names>G</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Ricart</surname><given-names>W</given-names></name><name><surname>Rieusset</surname><given-names>J</given-names></name><etal/></person-group><article-title>Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization</article-title><source>Diabetes Care.</source><year>2014</year><volume>37</volume><fpage>1375</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.2337/dc13-1847</pub-id><pub-id pub-id-type="pmid">24478399</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abente</surname><given-names>EJ</given-names></name><name><surname>Subramanian</surname><given-names>M</given-names></name><name><surname>Ramachandran</surname><given-names>V</given-names></name><name><surname>Najafi-Shoushtari</surname><given-names>SH</given-names></name></person-group><article-title>MicroRNAs in obesity-associated disorders</article-title><source>Arch Biochem Biophys.</source><year>2016</year><volume>589</volume><fpage>108</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2015.09.018</pub-id><pub-id pub-id-type="pmid">26416722</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrizas</surname><given-names>M</given-names></name><name><surname>Brugnara</surname><given-names>L</given-names></name><name><surname>Esteban</surname><given-names>Y</given-names></name><name><surname>Gonzalez-Franquesa</surname><given-names>A</given-names></name><name><surname>Canivell</surname><given-names>S</given-names></name><name><surname>Murillo</surname><given-names>S</given-names></name><name><surname>Gordillo-Bastidas</surname><given-names>E</given-names></name><name><surname>Cusso</surname><given-names>R</given-names></name><name><surname>Cadefau</surname><given-names>JA</given-names></name><name><surname>Garcia-Roves</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention</article-title><source>J Clin Endocrinol Metab.</source><year>2015</year><volume>100</volume><fpage>E407</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1210/jc.2014-2574</pub-id><pub-id pub-id-type="pmid">25532038</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalyfa</surname><given-names>A</given-names></name><name><surname>Kheirandish-Gozal</surname><given-names>L</given-names></name><name><surname>Bhattacharjee</surname><given-names>R</given-names></name><name><surname>Khalyfa</surname><given-names>AA</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name></person-group><article-title>Circulating microRNAs as potential biomarkers of endothelial dysfunction in obese children</article-title><source>Chest.</source><year>2016</year><volume>149</volume><fpage>786</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1378/chest.15-0799</pub-id><pub-id pub-id-type="pmid">26270249</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">American Diabetes Association. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care. 2000;23:381&#x02013;9.</mixed-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>MA</given-names></name><name><surname>Gutin</surname><given-names>B</given-names></name><name><surname>Le</surname><given-names>NA</given-names></name><name><surname>Karp</surname><given-names>W</given-names></name><name><surname>Litaker</surname><given-names>M</given-names></name><name><surname>Humphries</surname><given-names>M</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name><name><surname>Riggs</surname><given-names>S</given-names></name><name><surname>Owens</surname><given-names>S</given-names></name></person-group><article-title>Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children</article-title><source>Int J Obes Relat Metab Disord.</source><year>1999</year><volume>23</volume><fpage>889</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0800968</pub-id><pub-id pub-id-type="pmid">10490792</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>S</given-names></name><name><surname>Gutin</surname><given-names>B</given-names></name><name><surname>Allison</surname><given-names>J</given-names></name><name><surname>Riggs</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>M</given-names></name><name><surname>Litaker</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>W</given-names></name></person-group><article-title>Effect of physical training on total and visceral fat in obese children</article-title><source>Med Sci Sports Exerc.</source><year>1999</year><volume>31</volume><fpage>143</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/00005768-199901000-00022</pub-id><pub-id pub-id-type="pmid">9927022</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medrano</surname><given-names>M</given-names></name><name><surname>Maiz</surname><given-names>E</given-names></name><name><surname>Maldonado-Martin</surname><given-names>S</given-names></name><name><surname>Arenaza</surname><given-names>L</given-names></name><name><surname>Rodriguez-Vigil</surname><given-names>B</given-names></name><name><surname>Ortega</surname><given-names>FB</given-names></name><name><surname>Ruiz</surname><given-names>JR</given-names></name><name><surname>Larrarte</surname><given-names>E</given-names></name><name><surname>Diez-Lopez</surname><given-names>I</given-names></name><name><surname>Sarasua-Miranda</surname><given-names>A</given-names></name><etal/></person-group><article-title>The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study</article-title><source>Contemp Clin Trials.</source><year>2015</year><volume>45</volume><fpage>346</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.cct.2015.09.017</pub-id><pub-id pub-id-type="pmid">26408054</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keskin</surname><given-names>M</given-names></name><name><surname>Kurtoglu</surname><given-names>S</given-names></name><name><surname>Kendirci</surname><given-names>M</given-names></name><name><surname>Atabek</surname><given-names>ME</given-names></name><name><surname>Yazici</surname><given-names>C</given-names></name></person-group><article-title>Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents</article-title><source>Pediatrics</source><year>2005</year><volume>115</volume><fpage>e500</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1542/peds.2004-1921</pub-id><pub-id pub-id-type="pmid">15741351</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>TM</given-names></name><name><surname>Levy</surname><given-names>JC</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name></person-group><article-title>Use and abuse of HOMA modeling</article-title><source>Diabetes Care.</source><year>2004</year><volume>27</volume><fpage>1487</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.6.1487</pub-id><pub-id pub-id-type="pmid">15161807</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NHBPEP: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents</collab></person-group><article-title>The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents</article-title><source>Pediatrics.</source><year>2004</year><volume>114</volume><fpage>555</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1542/peds.114.2.S2.555</pub-id><pub-id pub-id-type="pmid">15286277</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittmeier</surname><given-names>KD</given-names></name><name><surname>Wicklow</surname><given-names>BA</given-names></name><name><surname>MacIntosh</surname><given-names>AC</given-names></name><name><surname>Sellers</surname><given-names>EA</given-names></name><name><surname>Ryner</surname><given-names>LN</given-names></name><name><surname>Serrai</surname><given-names>H</given-names></name><name><surname>Gardiner</surname><given-names>PF</given-names></name><name><surname>Dean</surname><given-names>HJ</given-names></name><name><surname>McGavock</surname><given-names>JM</given-names></name></person-group><article-title>Hepatic steatosis and low cardiorespiratory fitness in youth with type 2 diabetes</article-title><source>Obesity (Silver Spring)</source><year>2012</year><volume>20</volume><fpage>1034</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/oby.2011.379</pub-id><pub-id pub-id-type="pmid">22222927</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alderete</surname><given-names>TL</given-names></name><name><surname>Toledo-Corral</surname><given-names>CM</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name></person-group><article-title>Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth</article-title><source>Curr Diab Rep.</source><year>2014</year><volume>14</volume><fpage>455</fpage><pub-id pub-id-type="doi">10.1007/s11892-013-0455-z</pub-id><pub-id pub-id-type="pmid">24445905</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo-Corral</surname><given-names>CM</given-names></name><name><surname>Alderete</surname><given-names>TL</given-names></name><name><surname>Hu</surname><given-names>HH</given-names></name><name><surname>Nayak</surname><given-names>K</given-names></name><name><surname>Esplana</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name></person-group><article-title>Ectopic fat deposition in prediabetic overweight and obese minority adolescents</article-title><source>J Clin Endocrinol Metab.</source><year>2013</year><volume>98</volume><fpage>1115</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-3806</pub-id><pub-id pub-id-type="pmid">23386647</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>KA</given-names></name><name><surname>Ventura</surname><given-names>EE</given-names></name><name><surname>Fisher</surname><given-names>JQ</given-names></name><name><surname>Davis</surname><given-names>JN</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name><name><surname>Punyanitya</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>HH</given-names></name><name><surname>Nayak</surname><given-names>KS</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name></person-group><article-title>Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers</article-title><source>Diabetes Care.</source><year>2011</year><volume>34</volume><fpage>485</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.2337/dc10-0760</pub-id><pub-id pub-id-type="pmid">21270204</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicklow</surname><given-names>BA</given-names></name><name><surname>Griffith</surname><given-names>AT</given-names></name><name><surname>Dumontet</surname><given-names>JN</given-names></name><name><surname>Venugopal</surname><given-names>N</given-names></name><name><surname>Ryner</surname><given-names>LN</given-names></name><name><surname>McGavock</surname><given-names>JM</given-names></name></person-group><article-title>Pancreatic lipid content is not associated with beta cell dysfunction in youth-onset type 2 diabetes</article-title><source>Can J Diabetes.</source><year>2015</year><volume>39</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.jcjd.2015.04.001</pub-id><pub-id pub-id-type="pmid">26099932</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jae</surname><given-names>SY</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Choo</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>ES</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>WH</given-names></name></person-group><article-title>Fitness, body habitus, and the risk of incident type 2 diabetes mellitus in Korean men</article-title><source>Am J Cardiol.</source><year>2016</year><volume>117</volume><fpage>585</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2015.11.046</pub-id><pub-id pub-id-type="pmid">26721657</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>JR</given-names></name><name><surname>Ortega</surname><given-names>FB</given-names></name><name><surname>Rizzo</surname><given-names>NS</given-names></name><name><surname>Villa</surname><given-names>I</given-names></name><name><surname>Hurtig-Wennlof</surname><given-names>A</given-names></name><name><surname>Oja</surname><given-names>L</given-names></name><name><surname>Sjostrom</surname><given-names>M</given-names></name></person-group><article-title>High cardiovascular fitness is associated with low metabolic risk score in children: the European Youth Heart Study</article-title><source>Pediatr Res.</source><year>2007</year><volume>61</volume><fpage>350</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1203/pdr.0b013e318030d1bd</pub-id><pub-id pub-id-type="pmid">17314696</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senechal</surname><given-names>M</given-names></name><name><surname>Wicklow</surname><given-names>B</given-names></name><name><surname>Wittmeier</surname><given-names>K</given-names></name><name><surname>Hay</surname><given-names>J</given-names></name><name><surname>MacIntosh</surname><given-names>AC</given-names></name><name><surname>Eskicioglu</surname><given-names>P</given-names></name><name><surname>Venugopal</surname><given-names>N</given-names></name><name><surname>McGavock</surname><given-names>JM</given-names></name></person-group><article-title>Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth</article-title><source>Pediatrics.</source><year>2013</year><volume>132</volume><fpage>e85</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1542/peds.2013-0296</pub-id><pub-id pub-id-type="pmid">23796736</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leger</surname><given-names>LA</given-names></name><name><surname>Mercier</surname><given-names>D</given-names></name><name><surname>Gadoury</surname><given-names>C</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name></person-group><article-title>The multistage 20 metre shuttle run test for aerobic fitness</article-title><source>J Sports Sci.</source><year>1988</year><volume>6</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1080/02640418808729800</pub-id><pub-id pub-id-type="pmid">3184250</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Thompson PD, Arena R, Riebe D, Pescatello LS. ACSM&#x02019;s new preparticipation health screening recommendations from ACSM&#x02019;s guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013;12:215&#x02013;17.</mixed-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>AS</given-names></name><name><surname>Dolan</surname><given-names>LM</given-names></name><name><surname>Kimball</surname><given-names>TR</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Khoury</surname><given-names>PR</given-names></name><name><surname>Daniels</surname><given-names>SR</given-names></name><name><surname>Urbina</surname><given-names>EM</given-names></name></person-group><article-title>Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus</article-title><source>J Clin Endocrinol Metab.</source><year>2009</year><volume>94</volume><fpage>3740</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1210/jc.2008-2039</pub-id><pub-id pub-id-type="pmid">19723759</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>AS</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Urbina</surname><given-names>EM</given-names></name><name><surname>Kimball</surname><given-names>TR</given-names></name><name><surname>Dolan</surname><given-names>LM</given-names></name></person-group><article-title>Prediabetes: the effects on arterial thickness and stiffness in obese youth</article-title><source>J Clin Endocrinol Metab.</source><year>2014</year><volume>99</volume><fpage>1037</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1210/jc.2013-3519</pub-id><pub-id pub-id-type="pmid">24423349</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donath</surname><given-names>MY</given-names></name></person-group><article-title>Multiple benefits of targeting inflammation in the treatment of type 2 diabetes</article-title><source>Diabetologia.</source><year>2016</year><volume>59</volume><fpage>679</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-3873-z</pub-id><pub-id pub-id-type="pmid">26868493</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syrenicz</surname><given-names>A</given-names></name><name><surname>Garanty-Bogacka</surname><given-names>B</given-names></name><name><surname>Syrenicz</surname><given-names>M</given-names></name><name><surname>Gebala</surname><given-names>A</given-names></name><name><surname>Walczak</surname><given-names>M</given-names></name></person-group><article-title>Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents</article-title><source>Neuro Endocrinol Lett.</source><year>2006</year><volume>27</volume><fpage>453</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16892000</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinehr</surname><given-names>T</given-names></name><name><surname>Karges</surname><given-names>B</given-names></name><name><surname>Meissner</surname><given-names>T</given-names></name><name><surname>Wiegand</surname><given-names>S</given-names></name><name><surname>Fritsch</surname><given-names>M</given-names></name><name><surname>Holl</surname><given-names>RW</given-names></name><name><surname>Woelfle</surname><given-names>J</given-names></name></person-group><article-title>Fibroblast growth factor 21 and fetuin-A in obese adolescents with and without type 2 diabetes</article-title><source>J Clin Endocrinol Metab.</source><year>2015</year><volume>100</volume><fpage>3004</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1210/jc.2015-2192</pub-id><pub-id pub-id-type="pmid">26052728</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Reinehr T, Woelfle J, Wiegand S, Karges B, Meissner T, Nagl K, Holl RW. Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents. Pediatr Diabetes. 2016;17(4):281&#x02013;8.</mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Reinehr T, Karges B, Meissner T, Wiegand S, Stoffel-Wagner B, Holl RW, Woelfle J. Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines. J Pediatr. 2016.</mixed-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey-Lopez</surname><given-names>JP</given-names></name><name><surname>Vicente-Rodriguez</surname><given-names>G</given-names></name><name><surname>Ortega</surname><given-names>FB</given-names></name><name><surname>Ruiz</surname><given-names>JR</given-names></name><name><surname>Martinez-Gomez</surname><given-names>D</given-names></name><name><surname>De Henauw</surname><given-names>S</given-names></name><name><surname>Manios</surname><given-names>Y</given-names></name><name><surname>Molnar</surname><given-names>D</given-names></name><name><surname>Polito</surname><given-names>A</given-names></name><name><surname>Verloigne</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sedentary patterns and media availability in European adolescents: The HELENA study</article-title><source>Prev Med.</source><year>2010</year><volume>51</volume><fpage>50</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.ypmed.2010.03.013</pub-id><pub-id pub-id-type="pmid">20359491</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guay</surname><given-names>C</given-names></name><name><surname>Regazzi</surname><given-names>R</given-names></name></person-group><article-title>Circulating microRNAs as novel biomarkers for diabetes mellitus</article-title><source>Nat Rev Endocrinol.</source><year>2013</year><volume>9</volume><fpage>513</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2013.86</pub-id><pub-id pub-id-type="pmid">23629540</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guay</surname><given-names>C</given-names></name><name><surname>Regazzi</surname><given-names>R</given-names></name></person-group><article-title>New emerging tasks for microRNAs in the control of beta-cell activities</article-title><source>Biochim Biophys Acta.</source><year>2016</year><volume>1861</volume><fpage>2121</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2016.05.003</pub-id><pub-id pub-id-type="pmid">27178175</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>CE</given-names></name><name><surname>Elton</surname><given-names>RA</given-names></name><name><surname>Todd</surname><given-names>J</given-names></name><name><surname>Platt</surname><given-names>S</given-names></name></person-group><article-title>Indicators of socioeconomic status for adolescents: the WHO Health Behaviour in School-aged Children Survey</article-title><source>Health Educ Res.</source><year>1997</year><volume>12</volume><fpage>385</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1093/her/12.3.385</pub-id><pub-id pub-id-type="pmid">10174221</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>FB</given-names></name><name><surname>Lavie</surname><given-names>CJ</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name></person-group><article-title>Obesity and cardiovascular disease</article-title><source>Circ Res.</source><year>2016</year><volume>118</volume><fpage>1752</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.306883</pub-id><pub-id pub-id-type="pmid">27230640</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deiuliis</surname><given-names>JA</given-names></name></person-group><article-title>MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics</article-title><source>Int J Obes (Lond)</source><year>2016</year><volume>40</volume><fpage>88</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/ijo.2015.170</pub-id><pub-id pub-id-type="pmid">26311337</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalyfa</surname><given-names>A</given-names></name><name><surname>Gozal</surname><given-names>D</given-names></name></person-group><article-title>Exosomal miRNAs as potential biomarkers of cardiovascular risk in children</article-title><source>J Transl Med.</source><year>2014</year><volume>12</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-12-162</pub-id><pub-id pub-id-type="pmid">24912806</pub-id></element-citation></ref></ref-list></back></article>